Error rates are the ‘elephant in the room’ nobody wants to discuss when it comes to DAAs, says Luke Fitzgerald, CEO of MPS. In September the Pharmacy Board of Australia published revised guidelines that provide guidance to the profession on a range of issues. One of the key issues reviewed was Dose Administration Aids, with
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.